This study aimed at clarifying whether infectious diseases contributed to the development of rash or hepatitis in patients with trichloroethylene-related generalized skin disorders. Fifty-nine patients consecutively hospitalized between March 2002 and December 2003 and 59 healthy exposed workers selected on an age-matched basis in the patients' factories were enrolled in the study. Information on possible risk factors for rash and hepatitis was collected with structured checklists. Antibody titers were measured for hepatitis A, B and C viruses, Mycoplasma pneumoniae, herpes simplex viruses 1 and 2, Epstein-Barr virus, cytomegalovirus, human herpesvirus 6, measles and rubella virus. Thirty-six cases (59%) showed exfoliative dermatitis, 17 (28%) erythema multiforme, 4 (7%) StevensJohnson syndrome, and 4 (7%) toxic epidermal necrolysis. Before the onset of rash, 16 (27%) cases had received medication prescribed for the preceding fever, a main first symptom of the disorders. Marked increases in anti-human herpesvirus 6 IgG titer (≥256), which indicated viral reactivation, were noted in 14 (25%) patients, while no abnormal increase was detected in the controls (p<0.001). Anti-measles IgM titer was positive in 2 (7%) cases but not in the controls (p=0.49). The involvement of other known risk factors of rash or hepatitis was ruled out. These results suggest that part of trichloroethylene-related generalized cutaneous disorders occurring in China and drug-induced hypersensitivity syndrome overlap in terms of human herpesvirus 6 reactivation. (J Occup Health 2006; 48: 417-423) 
Generalized skin disorders, such as Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome (HS) or drug rash with eosinophilia and systemic symptoms are infrequent but serious adverse reactions to medicines, and can result in death or disability 1, 2) . The disorders are not caused solely by drugs. A close link between occupational solvent exposure, mostly trichloroethylene (TCE), and severe generalized skin disorders has been suggested by a series of case reports [3] [4] [5] [6] [7] [8] [9] [10] [11] . Recently, the number of patients suffering from TCE-related severe skin disorders has been increasing in Asia, especially the Philippines, Singapore, Taiwan and Guangdong Province, China 10, 12, 13) . In Guangdong, the Hospital for Occupational Diseases Control of Guangdong Province treated the first patient with the disorder in 1997, and 201 cases including 13 fatalities had been hospitalized by the end of 2005. Their clinical manifestations were in clear contrast to the irritating contact dermatitis caused by the solvent's defatting action. Low incidence, a certain period of exposure before disease onset, generalized rash, fever, lymphadenopathy, liver dysfunction and resulting fatalities, and recurrence just after minimal re-exposure exactly overlap characteristics of skin hypersensitive reactions to drugs 10, 14) . TCE is a ubiquitous solvent used worldwide, mostly for degreasing metals, and was in extensive use until the mid-80s, when its possible carcinogenicity for humans became a hotly debated issue after publication of rodent study results 15) . The reason why the TCE-related skin disorders are growing in number recently in Asia is a mystery, though it could partly be attributable to the rapid industrialization of the area and the resulting increase in the use of TCE and the exposed populations 10) , especially after the conclusion of the Montreal Protocol to phase out use and production of chlorofluorocarbons and 1,1,1-trichloroethane. To date, however, all publications on the clinical features of the disorders in the English literature have been confined to case reports of a single or a few cases, which have attracted only limited attention among clinicians and researchers worldwide. Factors associated with the disorders remain unknown except for trichloroethylene exposure. The possible involvement of infectious diseases, which can be expected from the analogy between the disorders and drug-induced HS, has never been explored.
In this study, we collected patients suffering from TCErelated generalized skin disorders, and clarified the prevalence of concomitant infection of viruses or bacteria in the cases. This is the first report showing that human herpesvirus 6 (HHV-6), the causative virus of exanthema subitum [16] [17] [18] , the reactivation of which has been reported in patients with drug-induced HS [19] [20] [21] [22] [23] [24] , can also be reactivated in those having developed skin disorders after occupational solvent exposure.
Methods

Subjects
This study was conducted according to the Declaration of Helsinki. All the subjects (or the responsible relatives in cases of physical incapacity) gave their written informed consent, and the Medical Ethics Committee of the Nagoya University Graduate School of Medicine approved the study protocols.
In principle, the Hospital for Occupational Diseases Control of Guangdong Province identified all patients with TCE-related generalized skin disorders occurring inside the province which has a population of over 79 million. Their skin manifestations were classified according to a diagnostic standard for occupational dermatoses (GBZ18-2002 4. the males and 37 females whose serum was available (22.9 ± 5.9 yr old) were enrolled in the present study (Table 1) . Fifty-nine control subjects (26 males and 33 females; 23.3 ± 5.3 yr old) were selected on an agematched (± 3 yr old) basis among healthy TCE-exposed workers in the 12 factories where the disorders occurred. Sex could not be matched due to the limited number of female workers in these factories. All the patients and controls were Han Chinese.
Serological assay
The patients' blood was taken on the 21st day of hospitalization, and the controls' blood on the day of the factory visit. The serum was stored at -80°C until analysis. We measured nonspecific IgE and antibody titers against the following infectious diseases potentially causing rash or hepatitis, or relating to HS or StevensJohnson syndrome 23, 25, 26) : measles, rubella, Mycoplasma pneumoniae, herpes simplex viruses 1 and 2, EpsteinBarr virus, cytomegalovirus, and HHV-6. IgG antibody titers against HHV-6 were measured by an indirect immunofluorescence assay as described previously 18) . The antibody titer was defined as the reciprocal of the serum dilution showing specific fluorescence. Due to the limitation of serum volume, antibody titers against hepatitis A, B, and C viruses, measured by enzyme immunoassay (EIA), were examined only in the patients along with other routine blood tests. The serological EIAs for measles, rubella, Mycoplasma pneumoniae, herpes simplex viruses 1 and 2, and cytomegalovirus, and the IgE measurement were conducted in the consecutive first 30 cases and corresponding controls, and the EIAs for Epstein-Barr virus were conducted for the last 28 and their controls.
Checklist
Using the structured checklists, the patients (or their families in cases of physical incapacity) were asked during hospitalization about their alcohol consumption, smoking and the following possible risk factors for rash, hepatitis and other infectious diseases: medication(s) received within 2 wk before the appearance of rash, the use of marijuana, use of sanitary chemicals including anthelmintic and cosmetics, drinking of unsanitary water, past history of allergic, immunological or hepatocystic diseases, and family history of TCE-related skin disorders. The controls were asked the same at their factories.
Statistical analyses
The frequencies of possible risk factors including positive virus titers were compared between the cases and controls with the chi-square test. When the expectations in the cells were less than 5, Fisher's exact probability test was used. Serum IgE concentrations were compared between the cases and the controls with Student's t-test. A two-tailed p value less than 0.05 was considered to indicate a statistically significant difference. The Bonferroni adjustment was applied to the p value for defining statistical significance of positive antibody titers against infectious diseases. All values were expressed as mean ± SD. JMP ver. 5.0.1 (SAS Institute Inc.) was used to analyze the data.
Results
Clinical manifestations of cases
More than half of the cases showed exfoliative dermatitis ( Table 1, Fig. 1A ). The remaining patients showed phenotypes of erythema multiforme spectrum: erythema multiforme minor or major, Stevens-Johnson syndrome and toxic epidermal necrolysis (Table 1, Figs. 1B, 1C and 1D). The typical clinical course started with fever and/or rash occurring on the extremities, face, neck or trunk after commencement of TCE use mostly as a degreasing solvent for 27.1 ± 9.8 days (range 4-53 d), and it showed little difference between phenotypes or sexes ( Table 1) . Liver dysfunction was the most frequently observed organ reaction other than skin at the time of hospitalization (Table 2) , however serological tests for hepatitis A, B, and C viruses ruled out acute hepatitis or its recrudescence (data not shown). Lymphadenopathy was remarkable in 41 patients (69%). C-reactive protein or the erythrocyte sedimentation rate did not increase in most of the 59 cases, which ruled out severe bacterial infection or active autoimmune diseases. Marked eosinophilia (>1,000/ mm 3 ) was observed in 5 patients (9%) out of 57 examined (Table 2 ). Serum IgE concentrations showed slight but significant (p=0.001) increase compared to controls [212.5 ± 88.0 IU/mL in the cases (n=30) and 137.6 ± 75.6 IU/mL in the controls (n=30)].
Antibody titers relating to rash or hepatitis
We observed marked increases in anti-HHV-6 IgG titer (≥256) in 14 patients out of 57 (25%) but not in the controls. The difference in the frequency of its abnormal increase between the cases and the controls was significant (Tables 2 and 3 ). Anti-measles IgM titer was positive in 2 of the 30 cases examined but not in the corresponding controls (p=0.49). The serological tests for rubella, Mycoplasma pneumoniae, herpes simplex viruses 1 and 2, Epstein-Barr virus and cytomegalovirus revealed no significant differences between the cases and the controls (Table 3) .
Medication, alcohol consumption, smoking, and other possible risk factors for rash or hepatitis
Forty-three cases (73%) did not receive medication before the onset of the rash while the remaining 16 (27%) took medicines for cold, e.g. antipyretics, on account of fever preceding rash. Although 4 female patients suffering from erythema multiforme were from the same factory, their periods on the job did not overlap. Alcohol consumption, smoking and all the other investigated possible risk factors did not reveal any significant differences between the cases and the controls (data not shown).
Fig. 1. Typical skin manifestations of trichloroethylene-related generalized skin disorders. (A) Exfoliative dermatitis (IgG titer to HHV-6 was 1:8). (B) Erythema multiforme (HHV-6 titer <1:8). (C) Stevens-Johnson syndrome (HHV-6 titer >1:256). (D) Toxic epidermal necrolysis (HHV-6 titer 1:16).
Discussion
The present study shows that there are a number of patients in southern China suffering from idiosyncratic generalized skin disorders similar to drug-induced hypersensitivity reactions subsequent to occupational TCE exposure. Though 27% of the patients had received some medication before the onset of rash, the medications were prescribed for the preceding fever, the main first symptom of the disorders. Other risk factors or agents possibly causing rash and/or hepatitis were generally not detected in these patients. In general, the adverse skin effects of solvents, responsible for as much as 20% of occupational dermatitis cases, are attributable not to allergic reaction but to irritation due to a local defatting action 27) . Thus, we are now attempting to determine the impurities or stabilizers, which are usually contained in the commercial TCE 15) , in the solvent used in the patients' factories. The exact TCE exposure level, i.e. environmental TCE concentrations and urinary excretion of its metabolites, is also under investigation to establish the best strategy to prevent the TCE-related generalized skin disorders.
The main finding of this study is that, of the examined titers against infectious diseases potentially causing rash or hepatitis, or relating to HS or Stevens-Johnson syndrome, only the frequency of HHV-6 reactivation showed a significant difference between the patients and the controls. This is the first report illustrating that HHV-6 can be reactivated in patients with skin disorders that had developed about 3-5 wk after commencement of exposure to TCE. Other potential confounders were either controlled or statistically equalized, though sex was not matched between the groups. Since the controls worked on the same factory lines as the patients before the disease onset, both cases and controls received nearly equivalent exposures. Thus, the HHV-6 reactivation was associated with the occurrence of the TCE-related generalized skin disorders, but maybe not with the level of TCE exposure.
HS, Stevens-Johnson syndrome and toxic epidermal necrolysis are parts of a spectrum of severe skin reactions to medicines such as nonsteroidal anti-inflammatory drugs, antibacterial sulfonamides, anticonvulsants, antibiotics and allopurinol 1, 28, 29) . Of these reactions, HHV-6 reactivation in adults has been reported in druginduced HS [19] [20] [21] [22] [23] [24] . However, in the present study, anti-HHV-6 titers increased also in some female patients suffering from diseases of erythema multiforme spectrum. Since the diagnostic standard for skin disorders used in this study was not exactly the same as Roujeau's classification 30) , the diagnosis of future patients needs to a Before Bonferroni adjustment. b VCA-IgG (+ or ±) and EBNA-IgG (-). c HHV-6 titers were not determined in two patients due to insufficiency of serum (see footnotes to Table 2 ).
be made according to his classification to discuss the involvement of HHV-6 in the development of each type of TCE-related skin disorders. HHV-6 infects most children between 6 months and 2 yr of age causing exanthema subitum 18) . The virus remains latent after primary infection and is then reactivated during immunosuppressive conditions such as lymphoproliferative disorders 31) and transplantation of bone marrow 32, 33) , kidney 34) or liver 35) , often in relation to the rash33). In drug-induced HS, IgG titers against HHV-6 rise remarkably between the 3rd and 4th weeks after the onset of clinical manifestations, and active HHV-6 replication precedes the rise in antibody titers 23) . In our cases, the IgG titer of one patient out of 9 preliminarily measured in the serum obtained at the 12th wk of hospitalization increased markedly, not in serum from the 3rd wk (see footnotes to Table 2 ), suggesting that the virus reactivation would have occurred more in the present cases. Since the blood sampling on the 21st d was a little too early to detect the reactivation in cases of drug-induced HS 36) , sequential blood sampling and virological tests different from serological assays will also be required in future study to know the exact timing of the reactivation and the role of HHV-6 in the clinical manifestations. In addition, the effectiveness of treatment with anti-herpesvirus agents must be considered.
As for the other infectious diseases examined, 2 cases showed an increased IgM titer for measles. CD46, a receptor for the measles virus 37, 38) , is also a cellular receptor for HHV-6 39) . Thus, these cases might have been susceptible to both HHV-6 and measles virus as reported in simultaneously co-infected cases 40) . In conclusion, the present study shows that at least part of the TCE-related generalized skin disorders in China overlap drug-induced HS in terms of HHV-6 reactivation. Solvent exposure histories possibly overlooked under medication histories must also be thoroughly reviewed in patients with drug-induced severe skin disorders.
